Here, we discovered that RRP9 overexpression was associated with incremented gemcitabine resistance, while silencing RRP9 expression led to increased sensitivity as shown by decreased colony formation and increased apoptosis in PC cell lines and significantly smaller tumors in our mouse xenograft tumor model. The gene discussed is RRP9; the disease is neoplasm.